Podcasts about Ophthalmology

Ocular complaints in children, such as a red or painful eye, sudden vision changes, or difficulty opening one eye, may be more than a minor concern. In pediatrics, these presentations can progress rapidly, and timely recognition is critical to preventing long-term vision impairment. A focused five-minute eye examination can often distinguish between emergent, urgent and routine conditions, making early assessment and intervention essential in the primary care setting.  This episode was recorded on the exhibit floor at the 2025 American Academy of Pediatrics National Conference in Denver, Colorado. Our guest is Donny Suh, MD, Professor of Ophthalmology and Chief of Pediatric Ophthalmology at the University of California, Irvine, and Children's Hospital of Orange County.  Some highlights from this episode include:  What a pediatrician can learn in five minutes  The most common ocular injuries that pediatrician's encounter  How pediatricians can support a patient before sending to a specialist  How understanding a patient's history can help a pediatrician For more information on Children's Colorado, visit: childrenscolorado.org. 

Dr. Rajesh Rao discusses the risk factors for epiretinal membrane formation in patients with diabetes mellitus with Dr. Shinji Kakihara, first author of the Ophthalmology Science article, “Epiretinal Membrane Is Associated with Diabetic Retinopathy Severity and Cumulative Anti-VEGF Injections.” Epiretinal Membrane Is Associated with Diabetic Retinopathy Severity and Cumulative Anti-VEGF Injections. Kakihara, Shinji et al. Ophthalmology Science, Volume 5, Issue 3. If you are unable to travel to AAO 2025, you can still enjoy the unparalleled program by registering for AAO 2025 Virtual. Get access to the annual meeting course and sessions recorded in Orlando, on-demand-only content specifically for the online platform, videos and posters, and CME credits. Learn more and register at aao.org/RegNow. Ophthalmology journal events at AAO 2025: ·        Peer Review Masterclass: A Practical Workshop for Journal Authors and Reviewers: Become a peer reviewer for the Academy's Ophthalmology journal, the leading journal in the field, and its companion journals, Ophthalmology Retina, Ophthalmology Glaucoma, and Ophthalmology Science. Dr. Emily Schehlein and Dr. Aaki Shukla, highly experienced reviewers and authors for various journals, will lead this free interactive workshop. Sponsored by Elsevier. ·        The Year in Literature: Editor's Choice Highlights From the Ophthalmology Journal Family: Join Ophthalmology's Editor-in-Chief, Dr. Russell Van Gelder, as he presents the top Ophthalmology articles on Sunday October 19 at 9:45am. Search “SYM31” in the Mobile Meeting Guide for more information. ·        Meet the Editor: Join us for an intimate conversation with Ophthalmology Editor-in-Chief, Dr. Russ Van Gelder, during the American Academy of Ophthalmology Annual Meeting. This special meet and greet offers ophthalmologists, residents, and researchers a unique chance to connect directly with one of our field's most influential editorial voices. Sunday, October 19, 3:30-4:30 pm, Academy Hub at the exhibit hall.

Send us a textThis week on the Less Stressed Life, we're talking vision, mitochondria, and light with ophthalmologist and UCL researcher Glen Jeffery. We explore why the retina is so energy hungry and how simple exposure to long wavelength light and even plain incandescent lighting can measurably support aging eyes.We dig into wavelength and dose, why morning timing matters most, what makes incandescent bulbs uniquely powerful, and practical ways to protect your eyes from modern indoor lighting.If you've ever battled screen related eye strain, worried about declining vision, or felt lost in the red light maze, this conversation brings clarity and simple next steps.KEY TAKEAWAYS: • Morning light best activates mitochondria and supports eye health • Just three minutes of red or long wavelength light can boost color vision • Benefits fade after about five days without continued exposure • Incandescent bulbs outperform LEDs for vision and energy support • Blue light and LEDs can drain mitochondrial function • Avoid lasers; low intensity LEDs or sunlight are safest • Daily natural light is the simplest, most effective therapyABOUT GUEST:Dr. Glen Jeffery is a Professor of Neuroscience at the UCL Institute of Ophthalmology. His research focuses on how aging and light exposure affect the retina and mitochondrial function. He has pioneered studies showing how specific wavelengths of light, including red and infrared, can improve visual performance and support healthy aging of the eye. His work bridges neuroscience, ophthalmology, and environmental health, emphasizing practical, light-based approaches to protect and restore vision. WHERE TO FIND: Email:  g.jeffery@ucl.ac.ukWHERE TO FIND CHRISTA:Website: https://www.christabiegler.com/Instagram: @anti.inflammatory.nutritionistPodcast Instagram: @lessstressedlifeYouTube: https://www.youtube.com/@lessstressedlifeNUTRITION PHILOSOPHY OF LESS STRESSED LIFE:

What happens when the “perfect” medical specialty no longer fits, and you dare to forge a new path?In this Echo Episode, Dr. Andrea Austin sits down with Dr. Kim Chan Ko, a former academic ophthalmologist and co-founder of Ketamine Startup, to explore her transition from repairing eyes to building a ketamine infusion clinic and teaching other physicians to do the same. Kim opens up about the challenges of practicing at a high-pressure Level 1 trauma center, the emotional weight of patient care, and the struggle to reconcile her identity as an ophthalmologist with her need for creativity and connection.Through personal development coaching and a circuitous journey, Kim discovered her passion for patient education, mentorship, and innovative healthcare models. She shares how embracing her multifaceted identity and saying “yes” to new opportunities—like video editing and coaching—paved the way for her current work. This episode dives into the power of redefining “physician,” the value of coaching for personal growth, and the courage to step away from traditional medicine to serve patients on your own terms.You'll hear how they:Navigate the emotional and professional challenges of leaving a specialty that no longer alignsUse coaching to uncover personal strengths and reframe physician identityEmbrace creative outlets like video editing to build new ventures in healthcareHighlight the growing trend of physicians starting independent practices, from ketamine clinics to telemedicineIf you're a physician feeling stuck or seeking a more fulfilling career, this episode offers honest insights and practical inspiration for your own journey.About the Guest“I am a multifaceted individual. I am just practicing medicine.” – Dr. Kim Chan KoDr. Kim Chan Ko is a board-certified ophthalmologist, diplomat of the American College of Lifestyle Medicine, and co-founder of Ketamine Startup, an online course teaching physicians to open ketamine infusion clinics. After years as creative director of Reset Ketamine in Palm Springs, CA, alongside her emergency physician husband, Kim stepped away from academic ophthalmology to pursue a path aligned with her passions for patient education, mentorship, and innovative healthcare. Her journey through burnout and coaching has shaped her mission to help physicians find clarity and build fulfilling careers.

Você já fez uma plicatura e se perguntou se o resultado seria o mesmo de uma ressecção? Então não perca esse episódio do StrabCast!O Journal Club desta semana teve como convidada a nossa querida ex-presidente Dra Dayane Issaho, que apresentou para nós seu artigo publicado no Journal of Ophthalmology em 2020: uma revisão sistemática e metanálise comparando plicaturas e ressecções em estrabismos horizontais.Vamos juntos?Link para o artigo: https://pmc.ncbi.nlm.nih.gov/articles/PMC7354662/

Dr. Edmund Tsui sits down with Drs. Akshay S. Thomas and Ogul E. Uner to discuss their IRIS Registry study of the prevalence, characteristics, and treatment patterns of pediatric noninfectious uveitis in the United States. From their Ophthalmology Retina article, “Prevalence, Treatment Patterns, and Outcomes of Pediatric Noninfectious Uveitis in the United States: An IRIS Registry Analysis” Prevalence, Treatment Patterns, and Outcomes of Pediatric Noninfectious Uveitis in the United States: An IRIS Registry Analysis. Uner, Ogul E. et al. Ophthalmology Retina. In press. You love learning, which is why you listen to this podcast. Get live pearls and even more insights from top speakers from around the world at AAO 2025, the largest ophthalmology meeting in the world! Register now and get ready for Orlando at aao.org/RegNow. Ophthalmology journal events at AAO 2025: Peer Review Masterclass: A Practical Workshop for Journal Authors and Reviewers: Become a peer reviewer for the Academy's Ophthalmology journal, the leading journal in the field, and its companion journals, Ophthalmology Retina, Ophthalmology Glaucoma, and Ophthalmology Science. Dr. Emily Schehlein and Dr. Aaki Shukla, highly experienced reviewers and authors for various journals, will lead this free interactive workshop. Sponsored by Elsevier. The Year in Literature: Editor's Choice Highlights From the Ophthalmology Journal Family: Join Ophthalmology's Editor-in-Chief, Dr. Russell Van Gelder, as he presents the top Ophthalmology articles on Sunday October 19 at 9:45am. Search “SYM31” in the Mobile Meeting Guide for more information. Meet the Editor: Join us for an intimate conversation with Ophthalmology Editor-in-Chief, Dr. Russ Van Gelder, during the American Academy of Ophthalmology Annual Meeting. This special meet and greet offers ophthalmologists, residents, and researchers a unique chance to connect directly with one of our field's most influential editorial voices. Sunday, October 19, 3:30-4:30 pm, Academy Hub at the exhibit hall.

In this episode, Dr. Matthew Tennant discusses the common issue of floaters in ophthalmology, exploring their physiological basis, patient experiences, and the limitations of current treatment options. The conversation delves into traditional methods like vitrectomy and YAG vitreolysis, highlighting their risks and effectiveness. Dr. Tennant also introduces PulseMedica, a startup developing innovative technology aimed at providing a safer, non-invasive solution for treating floaters, emphasizing the potential of femto laser technology. The episode concludes with reflections on the future of floater treatment and the ongoing challenges faced by both patients and clinicians.This episode is sponsored by Thea Pharma Canada - https://www.theapharma.caLearn more about PulseMedica at https://www.pulsemedica.com/Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support.

Professor Michel Michaelides, Professor of Ophthalmology, University College London and Consultant Ophthalmic Surgeon, Moorfields Eye Hospital

Michael Crossland, Senior Research Fellow, University College London (UCL) Institute of Ophthalmology and Rachel Canavan, PhD student in Psychology, UCL

Guest: Laura B. Enyedi, MD Pediatricians are often the first to encounter eye conditions that can range from common to life-threatening. Hear from Dr. Laura Enyedi as she shares highlights from her presentation on diagnosing childhood ocular disorders from the 2025 American Academy of Pediatrics (AAP) National Conference and Exhibition. Dr. Enyedi is a Professor of Ophthalmology and an Associate Professor in Pediatrics at Duke University School of Medicine in Durham, North Carolina.

Want to Start or Grow a Successful Business? Schedule a FREE 13-Point Assessment with Clay Clark Today At: www.ThrivetimeShow.com   Join Clay Clark's Thrivetime Show Business Workshop!!! Learn Branding, Marketing, SEO, Sales, Workflow Design, Accounting & More. **Request Tickets & See Testimonials At: www.ThrivetimeShow.com  **Request Tickets Via Text At (918) 851-0102   See the Thousands of Success Stories and Millionaires That Clay Clark Has Helped to Produce HERE: https://www.thrivetimeshow.com/testimonials/ Download A Millionaire's Guide to Become Sustainably Rich: A Step-by-Step Guide to Become a Successful Money-Generating and Time-Freedom Creating Business HERE: www.ThrivetimeShow.com/Millionaire   See Thousands of Case Studies Today HERE: www.thrivetimeshow.com/does-it-work/  

In this episode, Dr. David J Palmer, MD joins us as we dive into the topic of sustainability in ophthalmology. We explore three of the most environmentally pressing issues in ophthalmology today and hear about various studies, organizations, and resources that support efforts to make ophthalmology greener. 

Good vision isn't just about eye health, it's about quality of life. In this special interview, Dr. Vishal, Vice Chairman of Pushpagiri Eye Foundation, shares insights on why eye care matters, the latest advances in ophthalmology, and how community outreach is transforming access to vision care.

On this episode, Cathleen McCabe, MD, and Laura Enyedi, MD, chat with guests Mahsaw Mansoor, MD, and Emily Schehlein, MD live at the Women in Ophthalmology summer symposium about practicing sustainability in ophthalmology. ●       Welcome to this episode 0:11 ●       Introducing Mahsaw Mansoor, MD and Emily Schehlein, MD 0:38 ●       Tell us what we need to know about sustainability in ophthalmology? 0:51 ●       What's EyeSustain? 2:39 ●       Why should ophthalmologists care about sustainability? 4:14 ●       How much do healthcare systems contribute to greenhouse gas emissions? 7:32 ●       The importance of surveys in enacting change. 9:46 ●       The turning point of finally seeing results. 11:25 ●       What suggestions do you have for overcoming barriers in things we don't directly control? 12:55 ●       Tell us about some more resources from EyeSustain. 15:12 ●       Identify a champion in nursing, pharmacy. 18:49 ●       We hope our listeners visit EyeSustain. 19:32 ●       Leaving an impact through your practice by championing sustainability. 20:26 ●       Alcohol-based scrub! 21:43 ●       Thank you. 22:29 Laura Enyedi, MD, is a professor of ophthalmology and pediatrics at Duke Eye Center and medical director of South Durham Ophthalmology in North Carolina. Cathleen McCabe, MD, is chief medical officer of Eye Health America and medical director of The Eye Associates in Sarasota, Florida. Mahsaw Mansoor, MD is an ophthalmologist at Advanced Vision Care, Los Angeles, California. Emily Schehlein, MD is a glaucoma and cataract surgeon with Brighton Vision Center, Ann Arbor, Michigan. We'd love to hear from you! Send your comments/questions to podcast@healio.com. Follow us on Twitter @Healio_OSN. Disclosures: The hosts and guests report no relevant financial disclosures.

CME credits: 1.00 Valid until: 16-09-2026 Claim your CME credit at https://reachmd.com/programs/cme/Real-World-Evidence-of-Photobiomodulation-Efficacy-in-Ocular-Indications/35952/ This CME activity focuses on multiwavelength photobiomodulation (PBM), an emerging therapy indicated for the treatment of dry age-related macular degeneration (AMD). Hear from leading researchers and retina specialists about the mechanism of action, how it is administered, its efficacy and safety profile, therapeutic durability, which patients may benefit the most, and how PBM would fit into the AMD treatment paradigm.

CME credits: 1.00 Valid until: 16-09-2026 Claim your CME credit at https://reachmd.com/programs/cme/Integration-of-Photobiomodulation-Therapy-into-the-Age-Related-Macular-Degeneration-Treatment-Landscape/35951/ This CME activity focuses on multiwavelength photobiomodulation (PBM), an emerging therapy indicated for the treatment of dry age-related macular degeneration (AMD). Hear from leading researchers and retina specialists about the mechanism of action, how it is administered, its efficacy and safety profile, therapeutic durability, which patients may benefit the most, and how PBM would fit into the AMD treatment paradigm.

CME credits: 1.00 Valid until: 16-09-2026 Claim your CME credit at https://reachmd.com/programs/cme/Patient-Centered-Care-and-Integration-of-Photobiomodulation-Therapy-into-Clinical-Practice/35950/ This CME activity focuses on multiwavelength photobiomodulation (PBM), an emerging therapy indicated for the treatment of dry age-related macular degeneration (AMD). Hear from leading researchers and retina specialists about the mechanism of action, how it is administered, its efficacy and safety profile, therapeutic durability, which patients may benefit the most, and how PBM would fit into the AMD treatment paradigm.

CME credits: 1.00 Valid until: 16-09-2026 Claim your CME credit at https://reachmd.com/programs/cme/Best-Practices-for-Optimized-Photobiomodulation-Treatment-Effect-Candidate-Selection/35949/ This CME activity focuses on multiwavelength photobiomodulation (PBM), an emerging therapy indicated for the treatment of dry age-related macular degeneration (AMD). Hear from leading researchers and retina specialists about the mechanism of action, how it is administered, its efficacy and safety profile, therapeutic durability, which patients may benefit the most, and how PBM would fit into the AMD treatment paradigm.

CME credits: 1.00 Valid until: 16-09-2026 Claim your CME credit at https://reachmd.com/programs/cme/Sustaining-Visual-Benefits-of-Photobiomodulation-in-Dry-Age-Related-Macular-Degeneration/35948/ This CME activity focuses on multiwavelength photobiomodulation (PBM), an emerging therapy indicated for the treatment of dry age-related macular degeneration (AMD). Hear from leading researchers and retina specialists about the mechanism of action, how it is administered, its efficacy and safety profile, therapeutic durability, which patients may benefit the most, and how PBM would fit into the AMD treatment paradigm.

CME credits: 1.00 Valid until: 16-09-2026 Claim your CME credit at https://reachmd.com/programs/cme/Anatomical-Outcomes-from-the-LIGHTSITE-III-Trial/35947/ This CME activity focuses on multiwavelength photobiomodulation (PBM), an emerging therapy indicated for the treatment of dry age-related macular degeneration (AMD). Hear from leading researchers and retina specialists about the mechanism of action, how it is administered, its efficacy and safety profile, therapeutic durability, which patients may benefit the most, and how PBM would fit into the AMD treatment paradigm.

CME credits: 1.00 Valid until: 16-09-2026 Claim your CME credit at https://reachmd.com/programs/cme/Clinical-and-Safety-Outcomes-from-the-LIGHTSITE-III-Trial/35946/ This CME activity focuses on multiwavelength photobiomodulation (PBM), an emerging therapy indicated for the treatment of dry age-related macular degeneration (AMD). Hear from leading researchers and retina specialists about the mechanism of action, how it is administered, its efficacy and safety profile, therapeutic durability, which patients may benefit the most, and how PBM would fit into the AMD treatment paradigm.

Send us a textDr. Adam Rogers, MD is Chief Executive Officer of NervGen Pharma Corp. ( https://nervgen.com/ ) a clinical-stage biotech company dedicated to developing innovative treatments to enable nervous system repair in the settings of traumatic injury and disease. NervGen's lead drug candidate, NVG-291, is being evaluated in mid stage clinical trials in an initial target indication, spinal cord injury. NervGen has initiated preclinical evaluation of a new development candidate, NVG-300, in models of ischemic stroke, amyotrophic lateral sclerosis (ALS) and spinal cord injury.Dr. Rogers is a board-certified ophthalmologist specializing in diseases and surgery of the retina and vitreous, and previously co-founded and served as CEO of Hemera Biosciences, a clinical stage gene therapy biotech company targeting dry age-related macular degeneration where he oversaw all aspects of the company until the Hemera assets were acquired in December 2020 by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson.From 2001 to 2020 Dr. Rogers served as an Assistant Professor of Ophthalmology at the New England Eye Center of Tufts Medical Center (Boston, MA). Dr. Rogers has published 29 articles in peer reviewed journals and co-authored two textbooks and numerous chapters in major ophthalmic textbooks. Since 2007 he has served on the board of One Family Inc., an organization whose mission is to end homelessness in Massachusetts. He is a member of the Emory University Board of Trustees. Dr. Rogers has a MD from Emory College and Emory School of Medicine.#SpinalCordInjury #SCI #IschemicStroke #AmyotrophicLateralSclerosis #ALS #NervGen #Rehabilitation #RegenerativeMedicine #RegenerativeBiology #ChondroitinSulfateProteoglycans #STEM #Innovation #Science #Technology #Research #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #Podcasting #ViralPodcastSupport the show

In this episode, Dr. Puente joins us for a conversation about disability in ophthalmology from a clinical perspective - exploring successes, identifying gaps, and sharing lessons that can help shape more accessible eye care for the future.

In this episode of The Retina Channel Podcast, Dr. Christina Weng, Professor of Ophthalmology at Baylor College of Medicine and Chair of DRCR Retina Protocol AO, discusses the pivotal trial evaluating home OCT monitoring in neovascular age-related macular degeneration (AMD). The conversation reviews the study's rationale, methodology, and key findings, with emphasis on how home-based imaging could transform treatment paradigms, refine injection strategies, and inform the future design of retina clinical trials.

In this episode, we review the high-yield topic ⁠Presbyopia ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠from the Ophthalmology section at ⁠⁠⁠⁠Medbullets.com⁠⁠⁠⁠⁠⁠Follow⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Medbullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbulletsLinkedin: https://www.linkedin.com/company/medbullets

Previous research on the safety of fluorescein angiography in adults has indicated that severe complications are rare, but due to few studies in the pediatric population, the true rates of complications are unknown. Dr. Edmund Tsui sits down with Dr. Nimesh A. Patel to discuss his study examining fluorescein angiography adverse events in pediatric patients. From his Ophthalmology Retina article, “Real-Time Adverse Events in Pediatric Fluorescein Angiography: IV vs Oral” Real-Time Adverse Events in Pediatric Fluorescein Angiography: IV vs Oral. Sorour, Osama et al. Ophthalmology Retina. In press. Don't miss the savings! Ophthalmology Journal Podcast listeners, this is the last chance to get savings for AAO 2025 registration. Learn with new courses, exchanging ideas with colleagues from around the world, the biggest ophthalmology Expo in the largest meeting, and more. The last day to save is Sept. 17. Hurry to register at aao.org/RegNow Ophthalmology journal events at AAO 2025: Peer Review Masterclass: A Practical Workshop for Journal Authors and Reviewers: Become a peer reviewer for the Academy's Ophthalmology journal, the leading journal in the field, and its companion journals, Ophthalmology Retina, Ophthalmology Glaucoma, and Ophthalmology Science. Dr. Emily Schehlein and Dr. Aaki Shukla, highly experienced reviewers and authors for various journals, will lead this free interactive workshop. Sponsored by Elsevier. The Year in Literature: Editor's Choice Highlights From the Ophthalmology Journal Family: Join Ophthalmology's Editor-in-Chief, Dr. Russell Van Gelder, as he presents the top Ophthalmology articles on Sunday October 19 at 9:45am. Search “SYM31” in the Mobile Meeting Guide for more information. Meet the Editor: Join us for an intimate conversation with Ophthalmology Editor-in-Chief, Dr. Russ Van Gelder, during the American Academy of Ophthalmology Annual Meeting. This special meet and greet offers ophthalmologists, residents, and researchers a unique chance to connect directly with one of our field's most influential editorial voices. Sunday, October 19, 3:30-4:30 pm, Academy Hub at the exhibit hall.

In this episode, we review the high-yield topic ⁠CMV Retinitis ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠from the Ophthalmology section at ⁠⁠⁠⁠Medbullets.com⁠⁠⁠⁠⁠⁠Follow⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Medbullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbulletsLinkedin: https://www.linkedin.com/company/medbullets

In this episode, we review the high-yield topic ⁠Eye Anatomy⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠from the Ophthalmology section at ⁠⁠⁠⁠Medbullets.com⁠⁠⁠⁠⁠⁠Follow⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Medbullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbulletsLinkedin: https://www.linkedin.com/company/medbullets

In this episode, we review the high-yield topic Optic Neuritis⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠from the Ophthalmology section at ⁠⁠⁠⁠Medbullets.com⁠⁠⁠⁠⁠⁠Follow⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Medbullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbulletsLinkedin: https://www.linkedin.com/company/medbullets

We discuss the observation that resolution of retinal fluid at one month in eyes with nAMD treated with aflibercept 8mg may herald longer duration treatment intervals at week 96 with Michael Stewart,, MD, Knights Templar Professor of Ophthalmology, Mayo Clinic, Jacksonville, Florida.

I recently had the pleasure of speaking at a great eye conference in Manila in the Philippines which was run by Professor Victor Caparas, the Chairman of Ophthalmology of The Medical City. He has built an incredible team and large department from scratch over the past few decades and in this podcast he reveals the secrets to success. He is an incredible ophthalmologist with a great passion for helping patients and teaching surgery. I am confident that you will glean valuable insights that will help you build your career and future. We feature a new podcast every week on Sundays and they are uploaded to all major podcast services (click links here: Apple, Google, Spotify) for enjoying as you drive to work or exercise. The full video of the podcast is here on CataractCoach as well as on our YouTube channel. Starting now we have sponsorship opportunities available for the top podcast in all of ophthalmology. Please contact us to inquire.

Jason M. Raidbard, MPA, FACMPE, Executive Administrator of the Department of Ophthalmology and Visual Sciences at UChicago Medicine and Biological Sciences, shares insights on opportunities for growth and development within healthcare organizations. He discusses financial strategies, alleviating burdens for staff, and adapting to new rule changes, while emphasizing the importance of recognizing organizational weaknesses to drive meaningful improvements.

Fall prevention is a major public health concern because of the physical and psychological risks associated with falls. Loss of visual function is a major risk factor for falls and may be a major contributor to fall risk among older adults. Dr. Emily Schehlein interviews Dr. C. Gustavo De Moraes and medical student Alexander F. Dagi on the relationships between rates of glaucomatous visual field progression, fear of falling, history of falls, and ancestry. From their Ophthalmology Glaucoma article, “Risk of Falls, Fear of Falling, and Rates of Visual Field Progression in Glaucoma in the African Descent and Glaucoma Evaluation Study.” Risk of Falls, Fear of Falling, and Rates of Visual Field Progression in Glaucoma in the African Descent and Glaucoma Evaluation Study. Dagi, Alexander F. et al. Ophthalmology Glaucoma. In press.   Just like there is something for everyone on the Ophthalmology Journal Podcast, there is something for everyone at AAO 2025! From lectures, to labs, to networking, to social events, and courses for everyone on your practice team. Plan your program with the Meeting Guide and make sure to register today at aao.org/RegNow   Ophthalmology journal events at AAO 2025: Peer Review Masterclass: A Practical Workshop for Journal Authors and Reviewers: Become a peer reviewer for the Academy's Ophthalmology journal, the leading journal in the field, and its companion journals, Ophthalmology Retina, Ophthalmology Glaucoma, and Ophthalmology Science. Dr. Emily Schehlein and Dr. Aaki Shukla, highly experienced reviewers and authors for various journals, will lead this free interactive workshop. Sponsored by Elsevier. The Year in Literature: Editor's Choice Highlights From the Ophthalmology Journal Family: Join Ophthalmology's Editor-in-Chief, Dr. Russell Van Gelder, as he presents the top Ophthalmology articles on Sunday October 19 at 9:45am. Search “SYM31” in the Mobile Meeting Guide for more information. Meet the Editor: Join us for an intimate conversation with Ophthalmology Editor-in-Chief, Dr. Russ Van Gelder, during the American Academy of Ophthalmology Annual Meeting. This special meet and greet offers ophthalmologists, residents, and researchers a unique chance to connect directly with one of our field's most influential editorial voices. Sunday, October 19, 3:30-4:30 pm, Academy Hub at the exhibit hall.

NICE, the National Institute for Health and Care Excellence has recently approved new treatment in England for people living with the eye condition Leber hereditary optic neuropathy (LHON) helped by Researchers at the University of Cambridge. RNIB Connect Radio's Toby Davey was joined by Patrick Yu-Wai-Man, Professor of Ophthalmology at the University of Cambridge who was involved in the research into using idebenone to treat Leber hereditary optic neuropathy (LHON) who explains more about the eye condition and how the NICE approved treatment might be appropriate for some people who have LHON. To find out more about the University of Cambridge research into the new treatment for Leber hereditary optic neuropathy (LHON) do visit the following pages of the University website - https://www.clinical-neuroscience.cam.ac.uk/news/first-ever-mitochondrial-disease-treatment-approved-nhs-england (Image shows the RNIB Connect Radio logo. On a white background ‘RNIB' written in bold black capital letters and underline with a bold pink line. Underneath the line: ‘Connect Radio' is written in black in a smaller font)

Drs. Zubair Ansari and Basil Williams join for a candid discussion regarding the state of the ophthalmology residency match, including a discussion of dropping match percentages and the introduction of preference signaling.

About the Guest(s): Dr. Parag Gandhi (host): Oculofacial plastic surgeon at Maryland Eye & Face and University of Maryland Hospitals in Baltimore. He is the Chair of the Global Outreach Committee of ASOPRS, has extensive experience leading medical missions, developing global ophthalmology programs, and two surgical mission trips to Ukraine with Face 2 Face. Dr. Raymond Cho: Clinical Professor and Director of Oculoplastic & Orbital Surgery at Ohio State University Wexner Medical Center. A retired U.S. Army Colonel and veteran of Operation Iraqi Freedom, Dr. Cho has participated in multiple missions to Ukraine with the Canadian Face the Future Foundation. Dr. Jorge Corona: Oculofacial plastic surgeon in private practice in Dallas, Texas, and a Clinical Associate Professor at Texas Tech University. He has extensive global medical mission experience, including four trips to Ukraine with LEAP Global Missions. Dr. Dave Russell: Oculofacial plastic surgeon at Kaiser Northern California, who has participated in two humanitarian missions to Ukraine with LEAP, contributing to complex trauma care and surgical training. Dr. Stuart Seiff: Emeritus Professor of Ophthalmology at UCSF and CEO of Pacific Center for Oculofacial & Aesthetic Plastic Surgery. He co-directed the Symposium on Wartime Ophthalmic Trauma in 2022, and has completed four surgical missions to Ukraine with LEAP Global. Episode Summary: In this compelling episode on time-urgent humanitarian efforts in Ukraine, Dr. Parag Gandhi hosts an esteemed panel of oculofacial plastic surgeons who discuss their inspiring work in Ukraine amidst ongoing conflict. The episode provides an in-depth look into the role of these surgical missions in both medical education and patient care of civilians and wounded soldiers, highlighting the transformative impact on both the Ukrainian medical community and the participating surgeons in training and practice. Throughout the discussion, the guests share their motivations and experiences, emphasizing the importance of global outreach in oculoplastic surgery, addressing wartime trauma, and the complexities of secondary trauma reconstructions seen in Ukraine. This episode underscores the essential need for humanitarian medical aid in conflict zones, and the power of medical collaboration across borders to foster resilience and adaptability in the face of adversity. Heroyam slava! Resources: Razom for Ukraine, the Co-Pilot Project: Umbrella NGO and surgical education program that unites American, Canadian, and Ukrainian surgeons, and all of the initiatives we discuss on this episode. Face 2 Face, Face the Future, and LEAP Global Missions: Key organizations supporting medical missions and training initiatives in Ukraine. ASOPRS Foundation: Backing efforts to foster educational initiatives for Ukrainian ophthalmologists to learn key aspects of oculofacial plastic surgery to meet current wartime needs. Friends of Chervonohrad: NGO involved in supporting many health initiatives, including surgical trips to Ukraine through fundraising efforts and pre-travel security assessments for teams. Christian Medical Association of Ukraine: Partnering in efforts to redefine medical practices and values. Links to learn more about the humanitarian missions and donate to support surgical education:   Razom for Ukraine, the Co-Pilot Project: https://www.razomforukraine.org/projects/cpp/   ASOPRS Foundation: https://www.asoprsfoundation.org/donate  

In July, the Centers for Medicare and Medicaid (CMS) proposed catastrophic changes to Medicare reimbursement systems that, if finalized, will significantly affect ophthalmology and all specialty care. The impact on cataract surgery reimbursements alone would amount to an 11% reduction in payment. In today's episode, host Dr. Andrew Pouw welcomes three guests to discuss these highly complex and concerning cuts: Dr. John McAllister, the Academy's Secretary for Federal Affairs; Brandy Keys, the Academy's Director of Health Policy; and Rebecca Hyder, the Academy's Vice President of Government Affairs. Listen, share, and advocate to help us prevent these changes. Related Academy Resources: Summary of CMS Medicare Physician Fee Schedule Impact of the Efficiency Adjustment Impact to Indirect Practice Expense (PE) For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Dr. Jeffrey Goldberg is Professor and Chair of Ophthalmology and Director of the Byers Eye Institute at Stanford University, a leading scientist in the development and degeneration of the visual system from eye to brain, and a practicing ophthalmologist and surgeon.This episode is brought to you by: Gamma AI design partner for effortless presentations, websites, social media posts, and more: https://gamma.app (use code TIM at checkout for one month off on their annual plan)Helix Sleep premium mattresses: https://HelixSleep.com/Tim (27% off on all mattress orders)AG1 all-in-one nutritional supplement: https://DrinkAG1.com/Tim (1-year supply of Vitamin D plus 5 free AG1 travel packs with your first subscription purchase.)Timestamps:[00:00:00] Start.[00:05:30] How do you solve a problem like presbyopia?[00:08:34] The athletic benefits of training supranormal (better than 20/20) vision.[00:11:49] Indigenous eye drops and FDA-approved pilocarpine for presbyopia.[00:14:05] Understanding basic eye anatomy.[00:17:27] Exploring AREDS 2, CoQ10, ginkgo, vitamin B3, and other supplements for vision.[00:23:00] Visual training devices and psychedelic-prompted brain plasticity.[00:25:12] Thoughts on visual training effectiveness and motor action requirements.[00:28:29] Concussion rehabilitation and visual perception exercises.[00:32:36] Red light and violet light therapy for myopia and mitochondrial health.[00:36:07] Vision loss correlation with cognitive decline and depression.[00:39:36] Presbyopia progression and psychological dependence on readers.[00:41:15] Cognito Therapeutics headset for Alzheimer's treatment.[00:46:46] Glaucoma basics: neurodegenerative disease and risk factors.[00:48:53] Eye pressure variability and diurnal cycles.[00:50:02] Cannabis effects on eye pressure and compound isolation.[00:51:47] Stem cell research for vision restoration.[00:53:09] Anti-inflammatory effects and immune system role in eye diseases.[00:55:15] Gut microbiome connection to glaucoma in animal models.[00:58:43] Metabolic syndrome and GLP-1 receptor agonists.[01:00:50] Microbiome sharing and future therapeutic possibilities.[01:03:31] Dry eye treatment: preservative-free tears and serum drops.[01:08:43] Vision screening recommendations and UV protection.[01:11:22] Full-spectrum light benefits vs. UV exposure.[01:13:27] Paradigm shifts: irreversible vision loss becoming reversible.[01:17:18] Convergence of neuroscience advances and biotech investment.[01:21:58] Miraculous mitochondria: health, transplants, and three-parent babies.[01:26:24] My family history concerns and metabolic health screening.[01:29:26] Exercise's biggest gain: going from none to some.[01:33:03] Clinical trial participation resources and parting thoughts.*For show notes and past guests on The Tim Ferriss Show, please visit tim.blog/podcast.For deals from sponsors of The Tim Ferriss Show, please visit tim.blog/podcast-sponsorsSign up for Tim's email newsletter (5-Bullet Friday) at tim.blog/friday.For transcripts of episodes, go to tim.blog/transcripts.Discover Tim's books: tim.blog/books.Follow Tim:Twitter: twitter.com/tferriss Instagram: instagram.com/timferrissYouTube: youtube.com/timferrissFacebook: facebook.com/timferriss LinkedIn: linkedin.com/in/timferrissPast guests on The Tim Ferriss Show include Jerry Seinfeld, Hugh Jackman, Dr. Jane Goodall, LeBron James, Kevin Hart, Doris Kearns Goodwin, Jamie Foxx, Matthew McConaughey, Esther Perel, Elizabeth Gilbert, Terry Crews, Sia, Yuval Noah Harari, Malcolm Gladwell, Madeleine Albright, Cheryl Strayed, Jim Collins, Mary Karr, Maria Popova, Sam Harris, Michael Phelps, Bob Iger, Edward Norton, Arnold Schwarzenegger, Neil Strauss, Ken Burns, Maria Sharapova, Marc Andreessen, Neil Gaiman, Neil de Grasse Tyson, Jocko Willink, Daniel Ek, Kelly Slater, Dr. Peter Attia, Seth Godin, Howard Marks, Dr. Brené Brown, Eric Schmidt, Michael Lewis, Joe Gebbia, Michael Pollan, Dr. Jordan Peterson, Vince Vaughn, Brian Koppelman, Ramit Sethi, Dax Shepard, Tony Robbins, Jim Dethmer, Dan Harris, Ray Dalio, Naval Ravikant, Vitalik Buterin, Elizabeth Lesser, Amanda Palmer, Katie Haun, Sir Richard Branson, Chuck Palahniuk, Arianna Huffington, Reid Hoffman, Bill Burr, Whitney Cummings, Rick Rubin, Dr. Vivek Murthy, Darren Aronofsky, Margaret Atwood, Mark Zuckerberg, Peter Thiel, Dr. Gabor Maté, Anne Lamott, Sarah Silverman, Dr. Andrew Huberman, and many more.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

  Prof. Schmidt-Erfurth is a Professor and the Past Chair of the Department of Ophthalmology at the Medical University of Vienna and the director of Vienna Reading Centre. She has been a pioneer in the application of AI in retinal image analysis. In this episode, she describes various applications of AI in retina research and the work that her group has been doing over the years. The following article is a review of the some of her work: Enzendorfer ML, Tratnig-Frankl M, Eidenberger A, Schrittwieser J, Kuchernig L, Schmidt-Erfurth U. Rethinking Clinical Trials in Age-Related Macular Degeneration: How AI-Based OCT Analysis Can Support Successful Outcomes. Pharmaceuticals (Basel). 2025 Feb 20;18(3):284. doi: 10.3390/ph18030284. PMID: 40143063; PMCID: PMC11945239.

In this episode, we review the high-yield topic ⁠Optic Neuritis⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠from the Ophthalmology section at ⁠⁠⁠⁠Medbullets.com⁠⁠⁠⁠⁠⁠Follow⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Medbullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbulletsLinkedin: https://www.linkedin.com/company/medbullets

John Golden's Linkedin: https://www.linkedin.com/in/goldenjohn/Vital Neuro Linkedin:  https://www.linkedin.com/company/vital-neuroChris Hoyd's Linkedin: https://www.linkedin.com/in/chrishoyd/ John Golden is the CEO of Vital Neuro. He has considerable experience in operational and technology leadership, and led the successful exit from EXOS, a previous company he founded and built, prior to joining Vital Neuro 7 years ago. John has spent his career dedicated to making high quality complex technologies into simple consumer products that people can use, and uses the Vital Neuro technology himself 3-4 times per day to stay on top of his game. John has led the company through the clinical development all the way to reality as a consumer facing product, with a guiding principle that neurofeedback technology should be as easy to use as regular headphones. Product in Healthtech is community for healthtech product leaders, by product leaders. For more information, and to sign up for our free webinars, visit www.productinhealthtech.com.

Welcome to the Sustainable Clinical Medicine Podcast! In this episode, Dr. Sarah Smith sits down with Dr. Michele Knox, an accomplished ophthalmologist, physician leader, and passionate physician development coach. Dr. Knox shares insights from her nearly 30-year career, reflecting on what made her journey in medicine sustainable and fulfilling. Together, they explore the importance of building strong medical teams, cultivating community within healthcare, and finding purpose both inside and outside of clinical practice. Dr. Knox opens up about the challenges and rewards of working in a large group practice, her transition into coaching and leadership roles, and the lessons she's learned supporting early-career physicians. You'll hear practical strategies on how to delegate effectively, set personal boundaries, and prioritize wellness—both for yourself and your patients. Plus, Dr. Knox offers thoughtful advice on navigating patient satisfaction, self-compassion, and seeking support when burnout strikes. If you're a clinician looking for realistic and actionable ways to create a more sustainable, joyful, and balanced practice, you won't want to miss this episode. Get ready for an inspiring conversation about resilience, mentorship, and the power of community in medicine. Here are 3 key takeaways from this episode: Community Matters: Building and maintaining a supportive professional network—friends, mentors, and coaches—is essential for resilience and long-term sustainability in medicine. You're never alone, and sharing experiences can make all the difference through the ups and downs. Delegate & Elevate: Practicing at the top of your training means focusing on work only you can do, while entrusting support staff with the rest. Streamlining workflow not only benefits physicians but also improves patient care and reduces burnout. Life Beyond Medicine: Cultivating interests and relationships outside of clinical practice is vital. Hobbies, leadership roles, and simply giving yourself permission to rest can replenish your energy and passion for your work. Meet Dr. Michele Knox: Michele Knox, MD, Certified Physician Development Coach. Canadian Medical School & Ophthalmology residency, fellowship in US, stayed in SF Bay Area. Career in ophthalmology and physician leadership at very large group practice, recently retired and now giving back as Physician Development Coach, coaching through University Alumni Association & non profits. -------------- Would you like to view a transcript of this episode? Click here **** Charting Champions is a premiere, lifetime access Physician only program that is helping Physicians get home with today's work done. All the proven tools, support and community you need to create time for your life outside of medicine. Learn more at https://www.chartingcoach.ca **** Enjoying this podcast? Please share it with someone who would benefit. Also, don't forget to hit “follow” so you get all the new episodes as soon as they are released. **** Come hang out with me on Facebook or Instagram. Follow me @chartingcoach to get more practical tools to help you create sustainable clinical medicine in your life. **** Questions? Comments? Want to share how this podcast has helped you? Shoot me an email at admin@reachcareercoaching.ca. I would love to hear from you.

In this week's episode of the BroadEYE Podcast, hosts Dr. Shawn Maloney and Dr. Carlos Quezada-Ruiz sit down with Dr. Wiley Chambers, recently retired Deputy Director of the Division of Ophthalmology at the U.S. Food and Drug Administration (FDA). With over 36 years at the FDA, Dr. Chambers offers a rare insider's perspective on regulatory science, ophthalmic drug development, and the evolution of clinical trial oversight. This episode explores: How ophthalmology regulation has changed over the decades Common pitfalls in pre-IND meetings and what smart innovators do differently Lessons learned from reviewing countless drug and biologic applications The future of FDA guidance in areas like rare disease, gene therapy, and digital endpoints Dr. Chambers also shares personal reflections on mentorship, scientific integrity, and his transition out of federal service after a distinguished career. About Our Guest Dr. Wiley Chambers served as a lead ophthalmic reviewer at the U.S. FDA from 1987 until his retirement in 2023. As Deputy Director of the Division of Ophthal

In this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo are live from Octane's Ophthalmology Technology Forum with guests Tibor Juhasz, PhD, Richard L. Lindstrom, MD, Sumit “Sam” Garg, MD and Jean-Pierre Hubschman, MD. Welcome to the Eyeluminaries podcast 00:05 Review of episode 33 00:49 Intro of Tibor Juhasz, PhD 01:35 Tell us about your background and how you changed LASIK, cataract and glaucoma surgery. 02:27 How is ViaLase impacting glaucoma treatment? 06:55 How the treatment works 08:24 The importance of having a good team 11:02 Intro of Richard L. Lindstrom, MD 12:58 What is your perspective on what is happening today and what changes are you hoping for? 14:28 Integrated eye care delivery 17:00 Dentistry, a future model for eye care 17:50 Post-graduate medical education is changing 19:09 Was there a technology that you thought was a slam dunk and failed? 23:01 Any technology that you didn't expect to take off? 24:37 Intro of Sumit “Sam” Garg, MD 26:58 What do you see changing in ophthalmology residency programs around the country? 28:52 How do you instruct young physicians to be collaborative in care? 30:42 If you weren't a cornea specialist (or a model) what would you be? 32:10 Advice for young ophthalmologists today? 33:42 Share a Jim Mazzo story with us! 35:28 Intro of Jean-Pierre Hubschman, MD 37:07 Why did you, with a robotics company, decide to start in cataract surgery? 38:23 How do you become more efficient in robotic surgery? 41:00 How do we work on the economic side of this? 43:38 What's it like running a company vs being a retina surgeon? 44:46 Give us your feedback 48:16 Thanks for listening 48:30   Tibor Juhasz, PhD, is the founder and CEO of ViaLase Inc. He was also the co-founder of IntraLase and LenS. Richard L. Lindstrom, MD, is the founder and an attending surgeon at Minnesota Eye Consultants, an adjunct professor emeritus at the University of Minnesota, department of ophthalmology as well as the global chief medical editor of Ocular Surgery News. Sumit “Sam” Garg, MD, is the medical director at the Gavin Herbert Eye Institute at UC Irvine. Jean-Pierre Hubschman, MD, is the co-founder and CEO of Horizon Surgical Systems.   We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. Healio could not confirm disclosures for Garg, Hubschman, Juhasz, and Lindstrom at the time of publication.

The episode is sponsored by The Eye Vets and was recorded on site during the 2025 Fetch Nashville conference. Watch the full video here. Benjamin Bergstrom, DVM, MS, DACVO, is originally from the rural, small town of Rockton, Illinois. He received his bachelor's degree in 2009 followed by his Doctorate in Veterinary Medicine in 2013 from the University of Illinois at Urbana-Champaign. He then completed a one-year Small Animal rotating internship at the University of Georgia in Athens. Immediately following his rotating internship, he traveled back to the Midwest where he completed a three-year residency in Comparative Ophthalmology at Purdue University in 2017. As a board-certified Veterinary Ophthalmologist, Bergstrom began practicing in Nashville in 2017. In 2023, Bergstrom pursued a dream of becoming an independent practice owner and opened The Eye Vets in Nashville. Through a combination of in-person consultations and telecollaboration, Bergstrom aims to provide compassionate, innovative veterinary eye care to the greater Nashville area and beyond.

WAIT... AM I GOING BLIND? "Irene, If things continue, you'll have vision loss." "I thought I was here to get a cleaning... I mean, new glasses!"    After a routine eye exam, I left with more than just a new prescription; I walked out with a moment of clarity and panic. While I was distracted wondering how much my insurance would cover for new sunglasses, the optometrist said something that stopped me cold: "Your eyes are 200% worse this year than they were last year." It wasn't vague. It wasn't sugar-coated. It was direct, backed by a scan, and paired with a clear treatment plan. If I didn't follow through with the exercises, medical devices, and recommendations, I could face long-term vision loss. Simple. Clear. Urgent. And it hit me: this is exactly what patients need from us in the dental chair, clarity without judgment, and a transparent, actionable path forward. In this episode of Op Talk, Vic and I explore how that one appointment reshaped the way I approach communication and education in my operatory. We often expect compliance, but fail to deliver the kind of information that actually empowers patients to act. If they don't understand the problem, they won't prioritize the solution.  

Want to Start or Grow a Successful Business? Schedule a FREE 13-Point Assessment with Clay Clark Today At: www.ThrivetimeShow.com   Join Clay Clark's Thrivetime Show Business Workshop!!! Learn Branding, Marketing, SEO, Sales, Workflow Design, Accounting & More. **Request Tickets & See Testimonials At: www.ThrivetimeShow.com  **Request Tickets Via Text At (918) 851-0102   See the Thousands of Success Stories and Millionaires That Clay Clark Has Helped to Produce HERE: https://www.thrivetimeshow.com/testimonials/ Download A Millionaire's Guide to Become Sustainably Rich: A Step-by-Step Guide to Become a Successful Money-Generating and Time-Freedom Creating Business HERE: www.ThrivetimeShow.com/Millionaire   See Thousands of Case Studies Today HERE: www.thrivetimeshow.com/does-it-work/  

Dr. Ravi D. Goel, MD is a board-certified ophthalmologist and cataract surgeon at Regional Eye Associates in Cherry Hill, NJ. He serves as Senior Secretary for Ophthalmic Practice and Trustee of the American Academy of Ophthalmology. A passionate advocate for patient education, he creates ophthalmology and cataract surgery education content at ProtectingSight.com. Dr. Goel is also Chair of the AMA Ophthalmology Section Council and an Instructor at Wills Eye Hospital. His expertise spans ophthalmic innovation and practice management.https://www.seniorcareauthority.com/resources/boomers-today/

Learn what age-related macular degeneration (AMD) isWhat causes AMDThe types of AMDThe update on NAION - listen to last year's podcast all about itWhy we aren't too concernedClick here to join Dr. Spencer's online clinic VineyardClick to read the JAMA AMD articleClick to read the Ophthalmology journal AMD article

Today, we are joined by the esteemed Dr. Jay Chhablani, a distinguished professor of ophthalmology and vitreoretinal surgeon at the Department of Ophthalmology, University of Pittsburgh. As the Director of Clinical Research at the UPMC Vision Institute, Dr. Chhablani stands at the forefront of cutting-edge advancements in eye care. Embark on a fascinating exploration as Dr. Chhablani, a retina specialist and surgeon, shares his wealth of knowledge on retinal diseases, ranging from bothersome floaters to age-related macular degeneration. Delve into the intricacies of ophthalmic surgeries, including the delicate art of retinal detachment repair. Press play to discover: The origins and prevention of eye floaters, along with effective treatment approaches. Conditions warranting surgical intervention for floaters. Navigating through complications associated with common ophthalmic surgeries and procedures. Distinguishing between the two primary forms of macular degeneration. The mechanics of novel drug therapies in slowing the progression of retinal diseases. Eager to learn more? Tune in and explore more at Jay Chhablani, MD | Department of Ophthalmology | University of Pittsburgh. Episode also available on Apple Podcasts: apple.co/30PvU9C